explore -WSS

explore

author：comprehensive 2025-09-30 00:46:05 - browse：9

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： What is microchimerism and how does it affect maternal health?

WSS

With competition flaring, obesity drug hits goal in liver disease study

Brain injuries and the importance of a second opinion

Travis Kelce and the trap of celebrity vaccine endorsements

Explaining an after

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Medicare inequities exacerbate Puerto Rico’s health disparities

hotspot

explore

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

He's a Nobel laureate. Critics say he was misleading on Covid

Cancer drug shortages should be causing more outrage

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

At least 13 dead in Texas as scorching temps continue

NIH study of ME/CFS points to clear biological hallmarks

focus

Bill would allow buprenorphine prescription for addiction via telehealth

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Bill would allow buprenorphine prescription for addiction via telehealth

Gene therapy’s promise and the high cost of hope

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

hotspot

knowledge

focus

focus